{
    "Trade/Device Name(s)": [
        "BioPlex 2200 Syphilis Total & RPR Kit",
        "BioPlex 2200 Syphilis Total & RPR Calibrator Set",
        "BioPlex 2200 Syphilis Total & RPR Control Set"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K170413",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061247"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LIP",
        "GMQ",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "May 11, 2017",
    "Summary Letter Received Date": "February 10, 2017",
    "Submission Date": "February 9, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3830",
        "21 CFR 866.3820",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents",
        "Treponema pallidum nontreponemal test reagents",
        "Calibrator",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "Total (IgG/IgM) antibodies to Treponema pallidum",
        "Non-treponemal reagin antibodies"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Lithium heparin tube",
        "Sodium heparin tube",
        "K2 EDTA tube",
        "K3 EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Bio-Rad BioPlex 2200 System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex flow immunoassay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Multiplex immunoassay",
        "Antigen-antibody detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BioPlex 2200 Syphilis Total & RPR Kit, a multiplex flow immunoassay for detection of syphilis antibodies using the BioPlex 2200 System",
    "Indications for Use Summary": "Qualitative detection of total (IgG/IgM) antibodies to Treponema pallidum and qualitative detection/titer determination of non-treponemal reagin antibodies in human serum or plasma to aid in diagnosis of syphilis infection, used in conjunction with other laboratory tests and clinical findings; not intended for blood/plasma donor screening; for use with BioPlex 2200 System.",
    "fda_folder": "Microbiology"
}